This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Charter Medical Receives FDA 510(k) Clearance For Next Generation CELL FREEZE(R) Cryogenic Stem Cell Storage Containers

MANCHESTER, Conn., Dec. 20, 2010 (GLOBE NEWSWIRE) -- Charter Medical, a subsidiary of Lydall, Inc. (NYSE:LDL) announced today that it has received 510(k) clearance on its next generation Cell Freeze ® Cryogenic Storage Containers for Hematopoietic Progenitor Cells (HPC's). The issuance of the clearance by the U.S. Food and Drug Administration (FDA) allows Charter Medical to begin marketing the newly designed and expanded product offering for cryogenic storage, preservation, and transfer of HPC's. This next generation of containers offers a broader size range from 50 mL to 750 mL, redesigned configuration for easier use, and the same unique film as its predecessor product.

Joe Petrosky, Vice President of Global Marketing and Sales for Charter Medical, stated, "We are excited with this new product as it completes our freezing container platform which serves several high growth markets spanning from medical to cellular therapy and to bio / pharma processing."

Dale Barnhart, CEO of Lydall, stated, "I am pleased with the rapid deployment of this new product which was designed side by side with our customers. It demonstrates our commitment to being the supplier of choice as we grow our presence in these important life sciences markets."

About Lydall, Inc.

Lydall, Inc. is a New York Stock Exchange listed company, headquartered in Manchester, Connecticut.  The Company, with operations in the U.S., France, the Netherlands and Germany and sales offices in the U.S., Europe, and Asia, manufactures specialty engineered products for the thermal/acoustical and filtration/separation markets.  For more information, visit http://www.lydall.com . Lydall ® is a registered trademark of Lydall, Inc. in the U.S. and other countries.  All product names are trademarks of Lydall, Inc. or Charter Medical, Ltd.

CONTACT:  Charter Medical
          Peggy Niston, Global Product Manager
          (336) 768-6447
          Fax: (336) 774-1750
          pniston@lydall.com
          www.chartermedical.com
          3948-A Westpoint Blvd
          Winston-Salem, NC  27103
         
          Lydall, Inc.
          Peter M. Kurto, Vice President Business Development &
           Investor Relations
          860-646-1233
          Fax: 860-646-4917
          info@lydall.com
          www.lydall.com

company logo

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,024.06 +183.54 1.03%
S&P 500 2,108.29 +22.78 1.09%
NASDAQ 5,005.3910 +63.9670 1.29%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs